AU2003239789A1 - Therapeutic system for the controlled release of active ingredients - Google Patents

Therapeutic system for the controlled release of active ingredients

Info

Publication number
AU2003239789A1
AU2003239789A1 AU2003239789A AU2003239789A AU2003239789A1 AU 2003239789 A1 AU2003239789 A1 AU 2003239789A1 AU 2003239789 A AU2003239789 A AU 2003239789A AU 2003239789 A AU2003239789 A AU 2003239789A AU 2003239789 A1 AU2003239789 A1 AU 2003239789A1
Authority
AU
Australia
Prior art keywords
release
tablet
constituted
active ingredient
active ingredients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003239789A
Other languages
English (en)
Inventor
Ubaldo Conte
Lauretta Maggi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jagotec AG
Original Assignee
Jagotec AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec AG filed Critical Jagotec AG
Publication of AU2003239789A1 publication Critical patent/AU2003239789A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003239789A 2002-03-12 2003-03-12 Therapeutic system for the controlled release of active ingredients Abandoned AU2003239789A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT2002MI000514A ITMI20020514A1 (it) 2002-03-12 2002-03-12 Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
ITMI2002A000514 2002-03-12
PCT/EP2003/002536 WO2003075897A1 (en) 2002-03-12 2003-03-12 Therapeutic system for the controlled release of active ingredients

Publications (1)

Publication Number Publication Date
AU2003239789A1 true AU2003239789A1 (en) 2003-09-22

Family

ID=11449490

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003239789A Abandoned AU2003239789A1 (en) 2002-03-12 2003-03-12 Therapeutic system for the controlled release of active ingredients

Country Status (12)

Country Link
US (1) US20050095295A1 (https=)
EP (1) EP1482915B1 (https=)
JP (1) JP4664595B2 (https=)
CN (1) CN100528146C (https=)
AT (1) ATE454887T1 (https=)
AU (1) AU2003239789A1 (https=)
CA (1) CA2478406C (https=)
DE (1) DE60330949D1 (https=)
DK (1) DK1482915T3 (https=)
ES (1) ES2339438T3 (https=)
IT (1) ITMI20020514A1 (https=)
WO (1) WO2003075897A1 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1429744A1 (en) 2001-09-21 2004-06-23 Egalet A/S Morphine polymer release system
US20040234602A1 (en) 2001-09-21 2004-11-25 Gina Fischer Polymer release system
GB0203296D0 (en) 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
WO2004084868A1 (en) 2003-03-26 2004-10-07 Egalet A/S Morphine controlled release system
KR101164881B1 (ko) * 2003-09-19 2012-07-23 썬 파마슈티컬 인더스트리스 리미티드 경구용 약물 전달 시스템
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
CA2607272A1 (en) * 2005-05-09 2006-11-16 Azur Pharma Limited Formulations of mast cell stabilizing agents for delivery to the colon
NZ563846A (en) * 2005-06-03 2010-03-26 Egalet As A drug delivery system for delivering active substances dispersed in a dispersion medium
US8231902B2 (en) * 2005-11-18 2012-07-31 Accu-Break Technologies, Inc. Segmented pharmaceutical dosage forms
MX2008016349A (es) * 2006-06-19 2009-01-28 Accu Break Technologies Inc Formas segmentadas de dosificacion farmaceutica.
US8821928B2 (en) 2007-06-04 2014-09-02 Egalet Ltd. Controlled release pharmaceutical compositions for prolonged effect
CN102026628A (zh) * 2008-02-15 2011-04-20 太阳医药高级研发有限公司 具有降低崩裂效果的口服控释片剂
AU2009308885A1 (en) * 2008-10-31 2010-05-06 Mcneil-Ppc, Inc. Osmotic tablet with a compressed outer coating
CA2751627A1 (en) 2009-02-06 2010-08-12 Egalet Ltd. Pharmaceutical compositions resistant to abuse
CA2751667C (en) 2009-02-06 2016-12-13 Egalet Ltd. Immediate release composition resistant to abuse by intake of alcohol
NZ597283A (en) 2009-06-24 2013-07-26 Egalet Ltd Controlled release formulations
US9622979B2 (en) * 2011-06-29 2017-04-18 Sun Pharmaceutical Industries Limited Multilayered dosage form
AU2013285988A1 (en) 2012-07-06 2015-02-12 Egalet Ltd. Abuse deterrent pharmaceutical compositions for controlled release
CN104490838B (zh) * 2014-11-20 2017-03-01 河北医科大学 一种骨架型缓控释片剂及其制备方法和应用
WO2017136617A1 (en) 2016-02-04 2017-08-10 Cinrx Pharma, Llc Deuterated domperidone compositions and methods for therapy of disorders
US11364226B2 (en) 2017-06-30 2022-06-21 Cinrx Pharma, Llc Deuterated domperidone compositions, methods, and preparation
CA3023278C (en) * 2016-05-05 2019-04-30 Triastek, Inc. Controlled release dosage form
EA201992116A1 (ru) 2017-03-08 2020-01-29 СИНРКС ФАРМА, ЭлЭлСи Фармацевтические составы флороглюцинола и триметилфлороглюцинола
US12478612B2 (en) 2017-06-30 2025-11-25 Cindome Pharma, Inc. Deuterated domperidone compositions, methods, and preparation
JP7034343B2 (ja) * 2018-06-27 2022-03-11 アムニール コンプレックス プロダクツ リサーチ エルエルシー 自己調節性の浸透性胃保持性薬物送達システム
WO2020027927A1 (en) * 2018-07-30 2020-02-06 Insta Therapeutics, Inc. Sublingual diltiazem and methods of use
CN113274363B (zh) * 2021-04-29 2023-02-10 珠海润都制药股份有限公司 一种吲达帕胺制剂

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4503030A (en) * 1983-06-06 1985-03-05 Alza Corporation Device for delivering drug to certain pH environments
IT1201136B (it) * 1987-01-13 1989-01-27 Resa Farma Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive
US4810502A (en) * 1987-02-27 1989-03-07 Alza Corporation Pseudoephedrine brompheniramine therapy
IT1237904B (it) * 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
US5256440A (en) * 1992-06-22 1993-10-26 Merck & Co., Inc. Process for producing a tablet core aperture
US5376771A (en) * 1992-07-07 1994-12-27 Merck & Co., Inc. High speed process for preparing orifices in pharmaceutical dosage forms
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
IT1264517B1 (it) * 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
CN2213539Y (zh) * 1994-04-29 1995-11-29 天津市激光技术研究所 包衣上带有小孔的缓释药片
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
US5783793A (en) * 1996-02-29 1998-07-21 Merck & Co., Inc. Process for producing a plurality of holes in dosage forms using a laser beam deflected by an acousto-optic deflector
IL128043A (en) * 1997-05-30 2004-08-31 Osmotica Corp Multi-layered osmotic device for controlled delivery of active agents
US6004584A (en) * 1998-03-02 1999-12-21 The Procter & Gamble Company Highly absorbent body powders
CA2378829A1 (en) * 1999-07-20 2001-01-25 Merck & Co., Inc. Sustained release drug dispersion delivery device
AR026148A1 (es) * 2000-01-21 2003-01-29 Osmotica Argentina S A Dispositivo osmotico con pasaje preformado que aumenta de tamano
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento

Also Published As

Publication number Publication date
WO2003075897A1 (en) 2003-09-18
CA2478406C (en) 2011-02-08
JP2005526757A (ja) 2005-09-08
CN1649571A (zh) 2005-08-03
CA2478406A1 (en) 2003-09-18
JP4664595B2 (ja) 2011-04-06
US20050095295A1 (en) 2005-05-05
ES2339438T3 (es) 2010-05-20
EP1482915B1 (en) 2010-01-13
ATE454887T1 (de) 2010-01-15
DK1482915T3 (da) 2010-04-19
EP1482915A1 (en) 2004-12-08
CN100528146C (zh) 2009-08-19
ITMI20020514A1 (it) 2003-09-12
ITMI20020514A0 (it) 2002-03-12
DE60330949D1 (de) 2010-03-04

Similar Documents

Publication Publication Date Title
AU2003239789A1 (en) Therapeutic system for the controlled release of active ingredients
Janczura et al. The development of innovative dosage forms of the fixed-dose combination of active pharmaceutical ingredients
JP2005526757A5 (https=)
DE69918310D1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
AR005282A1 (es) Composición farmacéutica oral en la forma de un comprimido de unidades múltiples, uso de la misma para la preparación de medicamnetos, y procedimiento para su manufactura.
BR0315023A (pt) Distribuidor de composição anti-séptica de pele e método de preparar um distribuidor de composição anti-séptica de pele para uso
PT93170A (pt) Processo para a preparacao de dispositivos distribuidores nomeadamente de capsulas contendo um ingrediente activo
DE602004006497D1 (de) Wasserlösliches abgabeprodukt
PT2387391T (pt) Processo para o desenvolvimento de uma composição líquida a ser aplicada na forma de espuma sobre a pele e composição de aplicação tópica
KR900011486A (ko) 하이드로겔에 의해 작동되는 분배장치
WO2007103557A3 (en) Coating capsules with active pharmaceutical ingredients
AR018410A1 (es) Uso de una composicion para la manufactura de un medicamento que se usa para la prevencion o tratamiento de un estado agudo de asma y/o asma intermitentey/o episodios de asma cronico y metodo para la prevencion o tratamiento de un estado agudo de asma y/o asma intermitente y/o episodios de asma cron
AR036838A1 (es) Comprimido de varias capas de liberacion controlada, uso del mismo para la fabricacion de un medicamento util en el tratamiento de la fibromialgia y composicion farmaceutica que lo comprende.
BG108516A (en) Pharmaceutical formulation
AU780045B2 (en) Dosage forms having a barrier layer to laser ablation
MX9301435A (es) Metodo para producir dispositivos de suministro poroso.
DE60128263D1 (de) Ionenstärkenunabhängige pharmazeutische formulierung mit verzögerter freisetzung
PT1069902E (pt) Utilizacao de fosfolipidos na producao de um medicamento para a prevencao de adesoes
BRPI0315461B8 (pt) sistema terapêutico em forma de película
WO2003075894A8 (en) A system for the controlled release of active ingredients
PT1079867E (pt) Metodo de fabrico de um componente em po de um adesivo para utilizacao medica, utilizacao do referido componente em po e o referido componente em po
PA8548301A1 (es) Formulacion farmaceutica de sabor enmascarado y procedimiento para su preparacion
ES2007240A6 (es) Procedimiento para elaborar un preparado farmaceutico que asegura la absorcion transdernal del ingrediente activo.
JP2005526061A5 (https=)
RU2007142181A (ru) Лекарственная форма с модифицированным высвобождением

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase